American Century Companies’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-166,768
Closed -$4.38M 1439
2017
Q2
$4.38M Sell
166,768
-324,128
-66% -$7.97M ﹤0.01% 888
2017
Q1
$11.5M Sell
490,896
-443,442
-47% -$10.9M 0.01% 645
2016
Q4
$23.5M Buy
934,338
+28,945
+3% +$731K 0.03% 497
2016
Q3
$25.4M Sell
905,393
-94,775
-9% -$2.43M 0.03% 484
2016
Q2
$24.7M Buy
1,000,168
+37,114
+4% +$921K 0.03% 483
2016
Q1
$21.3M Buy
963,054
+644,192
+202% +$17.1M 0.02% 498
2015
Q4
$11.2M Buy
+318,862
New +$9.99M 0.01% 616
2014
Q4
Sell
-16,883
Closed -$412K 1513
2014
Q3
$412K Sell
16,883
-262,632
-94% -$6.96M ﹤0.01% 1312
2014
Q2
$7.99M Sell
279,515
-74,101
-21% -$2.06M 0.01% 774
2014
Q1
$9.89M Sell
353,616
-130,967
-27% -$3.22M 0.01% 715
2013
Q4
$10.4M Sell
484,583
-131,188
-21% -$2.38M 0.01% 710
2013
Q3
$8.17M Buy
615,771
+492,491
+399% +$6.63M 0.01% 766
2013
Q2
$1.71M Buy
+123,280
New +$1.75M ﹤0.01% 1120

Other funds holding PMC

American Century Companies's PMC Position: Q3 2017 in Review

American Century Companies sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 166,768 shares — an estimated $4.38M sold.

American Century Companies first reported a position in PMC in Q2 2013 and held it in 13 quarters. The position peaked at $25.4M in Q3 2016. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • American Century Companies reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • American Century Companies sold 166,768 PharMerica Corporation shares in Q3 2017, an estimated $4.38M.
  • American Century Companies first reported a position in PharMerica Corporation in Q2 2013 and held it in 13 quarters.
  • American Century Companies's PharMerica Corporation position peaked at $25.4M in Q3 2016.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on American Century Companies's 13F filing for Q3 2017, filed 1 Nov 2017.